The goal of this study is to find an effective and well-tolerated medical therapy for itching
due to liver disease. Persons with primary biliary cirrhosis or chronic hepatitis C are
currently being enrolled in the study. Persons participating in the study are given
sertraline, a medication which is also often used for depression,to treat their itching. The
dose is gradually increased as the effect on itching and any other potential side effects are
carefully monitored.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)